Shock. Shock, unspecified
Conditions
Interventions
Intervention 1: First intervention group: For patients in this group, vitamin C medicine will be prescribed at a dose of 30 mg/kg every 6 hours up to a maximum of 1500 mg/dose for 4 days or until admi
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Months to 15 Years
Inclusion criteria
Inclusion criteria: Children from 1 month to 15 years Suffering from shock (other than obstructive shock) Need vasopressors to maintain at least 5% of blood pressure percentile for age Parents' consent to participate in the study
Exclusion criteria
Exclusion criteria: Having active gastrointestinal bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of Vasopressor requirement. Timepoint: During the intervention. Method of measurement: Number of vasopressor injections.;Ventilator requirement. Timepoint: During the intervention. Method of measurement: PaCo2<50% and pH<7.3. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Creatinine. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;C-reactive protein (CRP). Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;White blood cell. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;Lactate. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazanin Zibanejad
Esfahan University of Medical Sciences
Outcome results
None listed